Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Status:
Completed
Trial end date:
2000-06-01
Target enrollment:
Participant gender:
Summary
To compare the newest CMV retinitis drug, cidofovir, with a regimen of the ganciclovir
intraocular device plus oral ganciclovir with respect to efficacy in preventing vision loss.
To compare a treatment regimen that incorporates highly active local therapy (ganciclovir
device) with a treatment regimen that does not.